President and Chief Executive Officer
Protomer Technologies Inc.
Pasadena California                   UNITED STATES
Dr. Alborz Mahdavi is the founder and CEO of Protomer Technologies, a pre-clinical stage biotechnology company in Pasadena California that develops novel types of insulin. Protomer Technologies is currently working with Sanofi and JDRF on development of a glucose-responsive insulin. Dr. Mahdavi has more than ten years of research and development experience in biotechnology including holding research appointments at MIT and Caltech. He received his PhD from Caltech where he currently holds a guest position in the department of chemistry and chemical engineering.